Pharmacological properties of bendazac (AF 983) with particular reference to its topical action on some experimental inflammatory processes.
D000085:Acetates / Q000627:therapeutic use*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D000959:Antihypertensive Agents / Q000494:pharmacology; D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects; D002351:Carrageenan / Q000037:antagonists & inhibitors; D002415:Cats; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control*; D005260:Female; D005561:Formates / Q000037:antagonists & inhibitors; D005730:Ganglionic Blockers / Q000494:pharmacology; D006099:Granuloma / Q000517:prevention & control; D006168:Guinea Pigs; D006854:Hydrocortisone / Q000627:therapeutic use*; D007249:Inflammation / Q000139:chemically induced / Q000517:prevention & control*; D007422:Intestines / Q000187:drug effects; D008297:Male; D051379:Mice; D009336:Necrosis / Q000517:prevention & control; D009541:Nictitating Membrane / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012702:Serotonin Antagonists; D013565:Sympatholytics; D014945:Wound Healing / Q000187:drug effects
D000085:Acetates; D000893:Anti-Inflammatory Agents; D000959:Antihypertensive Agents; D005561:Formates; D005730:Ganglionic Blockers; D012702:Serotonin Antagonists; D013565:Sympatholytics; D002351:Carrageenan; D006854:Hydrocortisone